Fitlife Brands Files 2024 Annual Report Amendment

Ticker: FTLF · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1374328

Sentiment: neutral

Topics: amendment, annual-report, disclosures

TL;DR

Fitlife Brands filed its 2024 10-K amendment on 4/29. Check for updates.

AI Summary

Fitlife Brands, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 29, 2025, provides updated information for the period. The company, formerly known as Bond Laboratories, Inc., is incorporated in Nevada and headquartered in Omaha, Nebraska.

Why It Matters

This amendment to the annual report provides updated financial and operational information for Fitlife Brands, Inc. for the fiscal year 2024, which is crucial for investors to assess the company's performance and outlook.

Risk Assessment

Risk Level: low — This filing is an amendment to an annual report, typically containing updated disclosures rather than significant new risks.

Key Numbers

Key Players & Entities

FAQ

What specific information is being amended in this 10-K/A filing?

The filing is an amendment (No. 1) to the annual report for the fiscal year ended December 31, 2024, indicating updated disclosures are being provided.

When was the original 10-K filed, or when was this amendment filed?

This amendment (10-K/A) was filed on April 29, 2025.

What is the primary business of Fitlife Brands, Inc.?

Fitlife Brands, Inc. is classified under the SIC code 2833 for Medicinal Chemicals & Botanical Products.

What was Fitlife Brands, Inc. formerly known as?

The company was formerly known as Bond Laboratories, Inc., with a name change date of August 31, 2006.

Where is Fitlife Brands, Inc. headquartered?

The company's principal executive offices are located at 5214 S. 136th Street, Omaha, NE 68137.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding FITLIFE BRANDS, INC. (FTLF).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing